Some say AIDS-drug risks are worth taking in Africa
PRETORIA -- Ranbaxy Laboratories in India withdrew seven antiretroviral drugs for AIDS patients last month from the World Health Organization list of prequalified medicines. The company acknowledged that it did not complete proper lab tests to make sure its copycat drugs were equivalent with brand-name ones.
Staying uninvolved while interviewing participants for a study about the effect of food shortages on H.I.V. treatment is often difficult, one researcher finds.